Total Voting Rights

RNS Number : 1250G
Kendrick Resources PLC
30 September 2024

Kendrick Resources Plc
(“Kendrick” or the “Company”)

Total Voting Rights

In accordance with the FCA’s Disclosure Guidance and Transparency Rules, as at 30 September 2024, the Company’s issued share capital consists of 250,248,152 Ordinary Shares of 0.03p, each with one voting right. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 250,248,152.

The above figure of 250,248,152 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

 

For additional information please contact:

Kendrick Resources Plc:

Chairman

 

Tel: +44 2039 616 086

Colin Bird

Novum Securities

Financial Adviser

Joint Broker

Tel: +44 207 399 9400

David Coffman / George Duxberry

Jon Bellis

 

Shard Capital Partners LLP

Joint Broker

Tel: +44 207 186 9952

Damon Heath / Isabella Pierre

 

 

About Kendrick Resources Plc

Kendrick Resources Plc is a mineral exploration and development company with projects primarily based across Scandinavia. The principal of its business is to explore the opportunities within the natural resources sector with a focus on battery, base, and precious metals including but not limited to vanadium and nickel. In doing so, the Company is looking to build a long term energy metals business in Scandinavia which delivers energy metals to Europe to help enable its renewable energy transformation by building a top tier energy metals production business.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 

END